Analyt Chim Acta:新技术高效检测雌激素含量

2015-01-05 佚名 生物谷

近日,一项发表于国际杂志Analytica Chimica Acta上的研究论文中,来自德州大学等处的研究人员通过研究开发了一种新方法,其可以帮助检测较少量样本中雌激素的含量,或将潜在改善癌症和其它疾病的检测方法。 我们都知道,雌激素在人体中发挥着重要的作用,而其也和肿瘤生长及阿尔兹海默氏症患者大脑中神经元的缺失等直接相关,但是在血液及其它体液中检测微量的雌激素非常困难,尤其是实验室有限的条

近日,一项发表于国际杂志Analytica Chimica Acta上的研究论文中,来自德州大学等处的研究人员通过研究开发了一种新方法,其可以帮助检测较少量样本中雌激素的含量,或将潜在改善癌症和其它疾病的检测方法。

我们都知道,雌激素在人体中发挥着重要的作用,而其也和肿瘤生长及阿尔兹海默氏症患者大脑中神经元的缺失等直接相关,但是在血液及其它体液中检测微量的雌激素非常困难,尤其是实验室有限的条件下更加困难。本文研究中研究人员将先进的质谱法同色谱仪器结合,开发了一种可以检测微量雌激素的新型敏感有效的方法,该方法可以在100微升样本中检测低于10万亿分之一含量的雌激素。

研究者Jose Barrera教授表示,这项新技术将雌激素的最低检出限又推向了一个新的水平,对于我们进行人类疾病、药学研究非常关键;质谱法和色谱法可以对复杂混合物中的分子进行分离、鉴别以及定量,该过程涉及液相色谱-电喷射离子化-串联质谱技术,其依赖于一种电荷衍生化的关键步骤,或者利用永久带电试剂来选择性地诱导雌激素,并且将雌激素从脂质和蛋白质中进行分离,最终进行雌激素的检测。

当前进行雌激素检测的方法依赖于抗体,即利用蛋白质检测系统,该方法耗时、可靠性较低,而且需要超过100微升的样本;而新方法不仅取样量少,而且可以在25分钟之内对样本进行检测。最后研究者Beinhauer说道,雌激素可以表现出重要的生物学功能,其不仅在个体的性发育、繁殖过程中扮演着重要角色,而且可以有效调节机体其它的功能,具有代谢活性的雌激素即便浓度非常低,但其可可以表现出较强的生物学活性,本文中开发出的新型雌激素检测技术对于研究人员疾病的发病机制将带来巨大帮助。

原始出处

Jana Beinhauera, b, 1, Liangqiao Bianc, d, 1, Hui Fane, Marek Šebelaa, b, Maciej Kukulac, d, Jose A. Barrerad, Kevin A. Schuge.Bulk derivatization and cation exchange restricted access media-based trap-and-elute liquid chromatography–mass spectrometry method for determination of trace estrogens in serum.Analyt Chim Acta.2014

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1903681, encodeId=cb06190368103, content=<a href='/topic/show?id=be285836438' target=_blank style='color:#2F92EE;'>#新技术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58364, encryptionId=be285836438, topicName=新技术)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d39f177, createdName=lixiao3326, createdTime=Sat Sep 26 10:37:00 CST 2015, time=2015-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1633312, encodeId=dee016333121f, content=<a href='/topic/show?id=377824e1c0' target=_blank style='color:#2F92EE;'>#ANA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2471, encryptionId=377824e1c0, topicName=ANA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=434d22047430, createdName=AspirantSuo, createdTime=Sun Feb 01 18:37:00 CST 2015, time=2015-02-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1849505, encodeId=7616184950558, content=<a href='/topic/show?id=61815385aa' target=_blank style='color:#2F92EE;'>#CTA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5385, encryptionId=61815385aa, topicName=CTA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ec9955, createdName=windight, createdTime=Thu Dec 17 20:37:00 CST 2015, time=2015-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1700008, encodeId=11911e00008d7, content=<a href='/topic/show?id=295524e541' target=_blank style='color:#2F92EE;'>#Anal#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2475, encryptionId=295524e541, topicName=Anal)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=de3a29999500, createdName=经常头晕, createdTime=Mon Dec 14 14:37:00 CST 2015, time=2015-12-14, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1903681, encodeId=cb06190368103, content=<a href='/topic/show?id=be285836438' target=_blank style='color:#2F92EE;'>#新技术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58364, encryptionId=be285836438, topicName=新技术)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d39f177, createdName=lixiao3326, createdTime=Sat Sep 26 10:37:00 CST 2015, time=2015-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1633312, encodeId=dee016333121f, content=<a href='/topic/show?id=377824e1c0' target=_blank style='color:#2F92EE;'>#ANA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2471, encryptionId=377824e1c0, topicName=ANA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=434d22047430, createdName=AspirantSuo, createdTime=Sun Feb 01 18:37:00 CST 2015, time=2015-02-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1849505, encodeId=7616184950558, content=<a href='/topic/show?id=61815385aa' target=_blank style='color:#2F92EE;'>#CTA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5385, encryptionId=61815385aa, topicName=CTA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ec9955, createdName=windight, createdTime=Thu Dec 17 20:37:00 CST 2015, time=2015-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1700008, encodeId=11911e00008d7, content=<a href='/topic/show?id=295524e541' target=_blank style='color:#2F92EE;'>#Anal#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2475, encryptionId=295524e541, topicName=Anal)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=de3a29999500, createdName=经常头晕, createdTime=Mon Dec 14 14:37:00 CST 2015, time=2015-12-14, status=1, ipAttribution=)]
    2015-02-01 AspirantSuo
  3. [GetPortalCommentsPageByObjectIdResponse(id=1903681, encodeId=cb06190368103, content=<a href='/topic/show?id=be285836438' target=_blank style='color:#2F92EE;'>#新技术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58364, encryptionId=be285836438, topicName=新技术)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d39f177, createdName=lixiao3326, createdTime=Sat Sep 26 10:37:00 CST 2015, time=2015-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1633312, encodeId=dee016333121f, content=<a href='/topic/show?id=377824e1c0' target=_blank style='color:#2F92EE;'>#ANA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2471, encryptionId=377824e1c0, topicName=ANA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=434d22047430, createdName=AspirantSuo, createdTime=Sun Feb 01 18:37:00 CST 2015, time=2015-02-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1849505, encodeId=7616184950558, content=<a href='/topic/show?id=61815385aa' target=_blank style='color:#2F92EE;'>#CTA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5385, encryptionId=61815385aa, topicName=CTA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ec9955, createdName=windight, createdTime=Thu Dec 17 20:37:00 CST 2015, time=2015-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1700008, encodeId=11911e00008d7, content=<a href='/topic/show?id=295524e541' target=_blank style='color:#2F92EE;'>#Anal#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2475, encryptionId=295524e541, topicName=Anal)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=de3a29999500, createdName=经常头晕, createdTime=Mon Dec 14 14:37:00 CST 2015, time=2015-12-14, status=1, ipAttribution=)]
    2015-12-17 windight
  4. [GetPortalCommentsPageByObjectIdResponse(id=1903681, encodeId=cb06190368103, content=<a href='/topic/show?id=be285836438' target=_blank style='color:#2F92EE;'>#新技术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58364, encryptionId=be285836438, topicName=新技术)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d39f177, createdName=lixiao3326, createdTime=Sat Sep 26 10:37:00 CST 2015, time=2015-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1633312, encodeId=dee016333121f, content=<a href='/topic/show?id=377824e1c0' target=_blank style='color:#2F92EE;'>#ANA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2471, encryptionId=377824e1c0, topicName=ANA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=434d22047430, createdName=AspirantSuo, createdTime=Sun Feb 01 18:37:00 CST 2015, time=2015-02-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1849505, encodeId=7616184950558, content=<a href='/topic/show?id=61815385aa' target=_blank style='color:#2F92EE;'>#CTA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5385, encryptionId=61815385aa, topicName=CTA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ec9955, createdName=windight, createdTime=Thu Dec 17 20:37:00 CST 2015, time=2015-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1700008, encodeId=11911e00008d7, content=<a href='/topic/show?id=295524e541' target=_blank style='color:#2F92EE;'>#Anal#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2475, encryptionId=295524e541, topicName=Anal)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=de3a29999500, createdName=经常头晕, createdTime=Mon Dec 14 14:37:00 CST 2015, time=2015-12-14, status=1, ipAttribution=)]
    2015-12-14 经常头晕

相关资讯

JCEM:肠道菌群多样性高的个体乳腺癌风险低

近日,来自美国国家癌症研究所的研究人员通过研究表示,绝经后女性如果机体中携带有多样化的肠道菌群,那么其机体的雌激素代谢产物或许对其健康更加有益,相关研究刊登于国际杂志Journal of Clinical Endocrinology &Metabolism (JCEM)上。 从20世纪70年代开始,科学家们就通过研究发现,构成肠道微生物组的肠道细菌会影响女性机体雌激素的功能,雌激素是

NEJM:抑制雌激素可提高绝经前乳腺癌患者预后

Figure 1. Randomization and Primary Analysis Populations. Figure 2. Primary Analysis Comparisons of Tamoxifen plus Ovarian Suppression (OS) with Tamoxifen Alone. 抑制卵巢雌激素产生可降低激素受体阳性的绝经前妇女早期乳腺癌复发率

Menopause:使用雌二醇阴道环应预防粘连

阴道雌二醇环可缓解阴道干燥、不适、瘙痒、性交疼痛和阴道上皮萎缩等绝经后症状,但阴道刺激是其已知并发症,若存在溃疡可考虑停止使用环,直到溃疡痊愈,以防止粘连。 近来,美国约翰 霍普金斯大学医学院妇产科的Pratts ME博士等在Menopause杂志上报道了1个病例:一名女性患者40岁时由于自然绝经开始接收复合激素治疗,直到52岁。多年来,患者无更年期症状,第一次随访中否认性活跃和阴道症状

雌激素受体阳性乳腺癌的新治疗方法

在2014年圣安东尼奥乳腺癌研讨会上,Loyola研究者和合作者报告了对于雌激素受体阳性乳腺癌,一种新的治疗方法。新的方法是称为γ分泌酶抑制剂(GSI)的新一类药物,能特异性抑制Notch和关闭负责癌细胞生长的关键基因。 现有的癌症药物有效地杀死成熟乳腺癌细胞,但有极少数未成熟的乳腺癌干细胞能抵抗此类药物。它们负责肿瘤的生长和发展,耐标准疗法是雌激素受体阳性乳腺癌死亡的主要病因。大约75%的

JNCI:豆浆并非人人都能喝

大豆已经成为很多国家的主要主粮,但大豆中富含植物雌激素,人在食用这些豆制类食物后,这些激素就会在体内模拟雌激素,过多食用可能会导致体内激素紊乱,而如果患有相关疾病如乳腺癌,则可能会进一步加重乳腺癌患病情况。尽管一些研究显示亚洲人的摄取大豆的比例在增加,乳腺癌的发生率却在下降,然而这并不能证实大豆对这些病患很友善。日前,一项对已经发生乳腺癌的女性进行研究发现,食用大豆能加重乳腺癌患者的患病情况。相关

Breast Cancer Res Treat:新的猜想:雌孕激素比例失调可能与乳腺癌的发生有关

Breast Cancer Res Treat:新的猜想:雌孕激素比例失调可能与乳腺癌的发生有关 肥胖与多种恶性肿瘤发生有关,然而多年来困扰我们的一个难题是:为什么肥胖增加绝经后女性乳腺癌的发生,却减少绝经前乳腺癌的发生?伦敦大学的Mitch Dowsett和Elizabeth Folkerd将给大家揭开这个谜底。 1.